BriaCell Therapeutics Corp. (BCTXW) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 26.44K | 27.45K | 0 | 0 | 0 | 5.18K | 5.16K | 5.18K | 5.09K | 5.17K | 5.15K | 5.08K | 0 | 4.84K | 4.84K | 4.8K | 0 | 4.69K | 4.69K | 4.69K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -26.44K | -27.45K | 0 | 0 | 0 | -5.18K | -5.16K | -5.18K | -5.09K | -5.17K | -5.15K | -5.08K | 0 | -4.84K | -4.84K | -4.8K | 0 | -4.69K | -4.69K | -4.69K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -429.99% | 100% | 100% | 100% | -0.14% | -0.33% | -2.03% | - | -6.95% | -6.38% | -5.88% | - | -3.2% | -3.23% | -2.39% | - | - | - | - |
| Operating Expenses | 8.55M | 6.33M | 7.17M | 5.15M | 5.77M | 9.23M | 9.83M | 8.5M | 7.71M | 5.68M | 4.49M | 5.4M | 5.91M | -2.3M | 3.65M | 2.29M | 1.59M | 4.81M | 190.15K | 380.37K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.44M | 1.52M | 1.49M | 1.49M | 1.36M | 1.57M | 1.57M | 1.65M | 2.54M | 1.82M | 1.43M | 2.15M | 1.37M | 1.85M | 1.94M | 1.41M | 994.66K | 3.68M | 20.74K | 227.49K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 7.11M | 4.81M | 5.68M | 3.67M | 4.41M | 7.66M | 8.26M | 6.86M | 5.17M | 3.86M | 3.05M | 3.25M | 2.87M | 2.92M | 1.71M | 875.64K | 594.44K | 406.2K | 165.59K | 116.84K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | -1K | 1K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | -1000K | 431 | 3.82K | 113 | 3.82K | 3.67K | 3.52K |
| Operating Income | 18.65M | -6.33M | -7.17M | -5.15M | -5.77M | -9.23M | -9.83M | -8.5M | -7.71M | -5.68M | -4.49M | -5.4M | -4.23M | -4.12M | -3.65M | -2.29M | -1.59M | -4.81M | -190.15K | -380.37K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 423.34% | 31.44% | 27.06% | 39.4% | 25.15% | -62.59% | -119.1% | -57.38% | -82.35% | -37.69% | -23.01% | -136.46% | -165.29% | 14.23% | -1817.9% | -500.73% | -154.8% | -858.71% | 86.62% | 67.6% |
| EBITDA | 18.68M | -6.3M | -7.14M | -5.13M | -5.7M | -9.23M | -9.82M | -8.5M | -7.7M | -5.67M | -4.48M | -5.4M | -4.22M | -4.12M | -3.64M | -2.28M | -1.59M | -4.8M | -186.33K | -376.56K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 427.92% | 31.7% | 27.3% | 39.68% | 26.05% | -62.63% | -119.18% | -57.42% | -82.42% | -37.76% | -23.04% | -136.79% | -165.68% | 14.25% | -1855.12% | -505.54% | -155.76% | -863.62% | 86.86% | 67.83% |
| D&A (Non-Cash Add-back) | 26.44K | 26.66K | 26.66K | 26.66K | 72.44K | 3.82K | 5.13K | 3.82K | 3.82K | 3.82K | 3.82K | 3.82K | 3.82K | 4.84K | 3.82K | 4.8K | 3.81K | 4.69K | 3.81K | 3.81K |
| EBIT | 18.51M | -6.19M | -7.17M | -5.15M | -5.77M | -9.23M | -9.83M | -8.5M | -2.42M | -5.68M | -4.49M | -5.4M | -15.75M | -6.13M | 11.16M | -27.53M | -2.8M | 3.01M | -190.15K | -405.6K |
| Net Interest Income | -49.53K | -10.35K | 46.83K | 13.05K | 0 | 15.61K | 81.59K | 190.81K | 208.78K | 253.49K | 240.59K | 188.35K | 82.36K | 35.99K | 12.08K | 5.33K | 81.06K | -62.42K | -45.79K | -15.72K |
| Interest Income | 86.51K | 26.63K | 46.83K | 13.05K | 0 | 15.61K | 81.59K | 190.81K | 208.78K | 253.49K | 320.11K | 256.59K | 82.36K | 46.23K | 15.36K | 6.3K | 60.55K | 39 | 0 | 0 |
| Interest Expense | 36.98K | 36.98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.03M | 188.35K | 0 | 35.99K | 12.08K | 979 | 0 | 62.46K | 45.79K | 15.72K |
| Other Income/Expense | -26.57M | 103.33K | 831.62K | -676K | 4.52M | 10.92M | -1.5M | 14.46M | 5.29M | 781.59K | -7.39M | 4.3M | -11.52M | -2.01M | 14.81M | -822K | -1.13M | 7.76M | -45.79K | -40.95K |
| Pretax Income | -7.92M | -6.22M | -6.34M | -5.83M | -1.25M | 1.69M | -11.33M | 5.96M | -2.42M | -4.89M | -11.88M | -1.11M | -577K | -10.02M | 11.16M | -3.11M | 1.04M | 2.95M | 180.06K | 233.91K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 171.85K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.58M | -35.99K | 0 | -107K | -1.21M | 0 | -44.01K | -14.5K |
| Effective Tax Rate % | -2.17% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -2006.41% | 0.36% | 0% | 3.44% | -116.84% | 0% | -24.44% | -6.2% |
| Net Income | -8.03M | -6.13M | -6.29M | -5.8M | -1.21M | 1.72M | -11.29M | 6M | -2.42M | -4.89M | -11.88M | -1.11M | -577K | -10.02M | 11.16M | -34.08M | -2.72M | 2.95M | 180.06K | 233.91K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -561.05% | -457.05% | 44.3% | -196.67% | 49.81% | 135.06% | 4.94% | 642.19% | -319.24% | 51.13% | -206.46% | 96.75% | 78.8% | -439.53% | 6098.35% | -14669.88% | -1414.5% | 521.04% | 109.56% | 114.2% |
| Net Income (Continuing) | -8.09M | -6.22M | -6.34M | -5.83M | -1.25M | 1.69M | -11.33M | 5.96M | -2.42M | -4.89M | -11.88M | -1.11M | -15.75M | -6.13M | 11.16M | -3M | -2.72M | 2.95M | -235.93K | -421.32K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -546.79K | -474.06K | -376.03K | -329.62K | -302.52K | -267.94K | -244.42K | -205.11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -4.26 | -1640.18 | -0.35 | -0.32 | -0.07 | 0.11 | -0.71 | -0.50 | -151.89 | -0.28 | -1.73 | 0.21 | -1.89 | 0.15 | 0.61 | 0.06 | -0.18 | 0.49 | -0.30 | -0.54 |
| EPS Growth % | -6220.47% | -1491172.73% | 50.7% | 36% | 99.96% | 139.29% | 58.96% | -338.1% | -7936.51% | -286.67% | -383.61% | 262.07% | -950% | -69.39% | 303.33% | 110.74% | 77.78% | 170% | 84.85% | 70.49% |
| EPS (Basic) | -4.26 | -1640.18 | -0.35 | -0.32 | -0.07 | 0.11 | -0.71 | 0.38 | -154.27 | -0.28 | -1.73 | 0.21 | -1.89 | 0.15 | 0.73 | 0.06 | -0.18 | 0.49 | -0.30 | -0.54 |
| Diluted Shares Outstanding | 1.88M | 3.73K | 18.03M | 18.03M | 18.03M | 15.98M | 15.98M | 16.68M | 15.92M | 15.52M | 15.52M | 15.52M | 15.36M | 15.52M | 18.41M | 15.37M | 15.24M | 4.74M | 771.96K | 771.96K |
| Basic Shares Outstanding | 1.88M | 3.73K | 18.03M | 18.03M | 18.03M | 15.98M | 15.98M | 15.98M | 15.68M | 15.52M | 15.52M | 15.52M | 13.63M | 15.36M | 15.3M | 15.24M | 15.24M | 4.74M | 771.96K | 771.96K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |